Development of the pharmaceutical practice: an alternative to recovery from the crisis of the Algerian pharmacy

Pharmaceutical practice around the world has much changed. It progressed from simple delivery of medicines with advice during the last decade to a more active role including notions of responsibility for results of engaged therapies and the delivery of services. The world health organization (WHO), along with the International Pharmaceutical Federation (IPF), made a study of this problem in order to set up orientations that may allow the health ally professional who is the pharmacist, to better answer the care requirements of the population and better control the cost of drugs. In Algeria, where the pharmacist outcome is essentially indexed on the commercial margin, the issue is more specific. In fact, through a progressive reduction of the purchasing power of the pharmacists since 1998, the commercial activity has largely replaced the activity linked to public health, calling into question the utility of the dispensary pharmacist as a health actor in society. It would appear to be necessary, in the light of the Classification of the Activities for the pharmaceutical practice, established by the WHO and the IPF in 2006, entitled “Enlargement of the pharmaceutical practice”, to pave the ground for the pharmacy profile of tomorrow in Algeria. This pharmacy will allow to better serve the population’s health. This approach is illustrated with the Jordanian and the Swiss examples. This includes the optimization of the resources for health ally professionals by establishing a performance-related remuneration (PRR). This may allow the creation of a project that may precise the role and missions of the pharmacist in order to maintain the quality of life of the patient in the context of a multidisciplinary approach. This article is largely inspired by a working document intended to be released and tried on the ground and revised.